Sector consensus Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 232.51 USD | -0.90% |
|
+1.40% | +16.56% |
| Jul. 29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| Jul. 20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 228.5 | -2.61% | 14 | ||||||
| 680.7 | +19.38% | 23 | ||||||
| 272.94 | +14.78% | 18 | ||||||
| 207 | +7.72% | 21 | ||||||
| 415.64 | +29.05% | 27 | ||||||
| 265,216.27 | +39.59% | 24 | ||||||
| 267.77 | +21.26% | 18 | ||||||
| 581.83 | +0.61% | 12 | ||||||
| 183.75 | +11.01% | 16 | ||||||
| 72.6 | +5.83% | 14 | ||||||
| 69.73 | -3.2% | 11 | ||||||
| 138.56 | +27.71% | 6 | ||||||
| 130.53 | -2.81% | 12 | ||||||
| 37.73 | +4.78% | 11 | ||||||
| 90.8 | +70.42% | 20 | ||||||
| 127.18 | +18.85% | 22 | ||||||
| 44.07 | +6.32% | 14 | ||||||
| 133.31 | -3.85% | 13 | ||||||
| 610.05 | +98.23% | 19 | ||||||
| 56 | +11.93% | 17 | ||||||
| Average | 13,478.25 | +18.75% | 17 | ||||||
| Weighted average by Cap. | 22,799.15 | +18.60% | 19 |
Select your edition
All financial news and data tailored to specific country editions
